Wong Hing C., Coogan Raymond, Intini Francesco P., Natile Giovanni, Marzilli Luigi G.
Department of Chemistry, Emory University, Atlanta, Georgia 30322, and Dipartimento Farmaco-Chimico, Università degli Studi di Bari, 70125 Bari, Italy.
Inorg Chem. 1999 Feb 22;38(4):777-787. doi: 10.1021/ic980987u.
A fundamental problem obscuring the role of the ammine and primary amine groups in the activity of clinically used Pt anticancer drugs is the dynamic character of the adducts with DNA and DNA constituents. Dynamic motion is slower in analogues containing only secondary or tertiary amines, but such agents are not used clinically. Recently we found that enclosing the N center within a piperidine (pip) ring greatly reduces dynamic motion. In this work, we test the hypothesis that a diamine with only one pip ring, 2-aminomethylpiperidine (pipen), would slow dynamic motion enough for insightful study of adducts with one site (cis to the primary amine) closely reflecting the coordination environment of clinically used drugs. Racemic pipen was prepared and resolved by improved methods. PtCl(2)(pipen) synthesized with the pipen enantiomer having an R configuration of the asymmetric carbon (determined on the basis of the alpha sign) has the S stereochemistry at the N asymmetric center. In the adduct (S,R)-pipenPt(5'-GMP)(2), restricted rotation of the two nonequivalent N7-coordinated 5'-GMP's about the Pt-N7 bonds potentially could lead to two head-to-tail (LambdaHT and DeltaHT) and two head-to-head (HH(1) and HH(2)) atropisomers. However, 1D and 2D NOESY NMR data at pH approximately 3 indicated the dominance of the two HT atropisomers in a LambdaHT:DeltaHT ratio of 2:1. Deprotonation of the phosphate group (pH 7) further stabilized the LambdaHT form, and the CD signal had the shape characteristic of a LambdaHT form with a positive peak at approximately 280 nm. However, at pH 9.5, where the 5'-GMP N1H was largely deprotonated, the NMR spectrum and the approximately 280 nm CD peak both revealed that the LambdaHT form had decreased. When the pH was jumped down to 6.9, the NMR signals of the LambdaHT form and the approximately 280 nm CD peak increased with a half-time of approximately 3 min. Thus, the pip ring lengthens the atropisomerization time from seconds for ethylenediaminePt(5'-GMP)(2) to minutes for (S,R)-pipenPt(5'-GMP)(2). This pH jump experiment indicates that the signs of the CD signal are opposite for the LambdaHT and DeltaHT forms. Changes with pH in both the relative abundance and shifts of the H8 signals of the LambdaHT and DeltaHT forms correlated with an increase in hydrogen bonding by the phosphate group of the 5'-GMP cis to the primary amine. The hydrogen bonding changes the 5'-GMP base tilt and hence the H8 chemical shift. Such information is not obtainable on 5'-GMP adducts of clinically used anticancer drugs.
一个掩盖氨和伯胺基团在临床使用的铂类抗癌药物活性中作用的基本问题是其与DNA及DNA成分加合物的动态特性。在仅含仲胺或叔胺的类似物中,动态运动较慢,但此类药物未在临床上使用。最近我们发现,将氮中心封闭在哌啶(pip)环内可大大降低动态运动。在这项工作中,我们测试了这样一个假设,即仅含一个pip环的二胺2-氨甲基哌啶(pipen)会使动态运动足够慢,以便深入研究与一个位点(与伯胺顺式)的加合物,该加合物能密切反映临床使用药物的配位环境。通过改进方法制备并拆分了外消旋的pipen。用具有不对称碳R构型(根据[α](D)符号确定)的pipen对映体合成的PtCl₂(pipen)在氮不对称中心具有S立体化学。在加合物(S,R)-pipenPt(5'-GMP)₂中,两个不等价的N7配位的5'-GMP围绕Pt-N7键的受限旋转可能会导致两种头对尾(ΛHT和ΔHT)和两种头对头(HH₁和HH₂)阻转异构体。然而,在pH约为3时的一维和二维NOESY NMR数据表明,两种HT阻转异构体占主导,ΛHT与ΔHT的比例为2:1。磷酸基团去质子化(pH 7)进一步稳定了ΛHT形式,CD信号具有ΛHT形式的特征形状,在约280 nm处有一个正峰。然而,在pH 9.5时,5'-GMP N1H大部分去质子化,NMR光谱和约280 nm的CD峰均显示ΛHT形式减少。当pH骤降至6.9时,ΛHT形式的NMR信号和约280 nm的CD峰以约3分钟的半衰期增加。因此,pip环将阻转异构化时间从乙二胺Pt(5'-GMP)₂的几秒延长至(S,R)-pipenPt(5'-GMP)₂的几分钟。这个pH跃变实验表明,ΛHT和ΔHT形式的CD信号符号相反。ΛHT和ΔHT形式的H8信号相对丰度和位移随pH的变化与与伯胺顺式的5'-GMP磷酸基团氢键增加相关。氢键改变了5'-GMP碱基倾斜度,从而改变了H8化学位移。此类信息在临床使用的抗癌药物的5'-GMP加合物中无法获得。